Posted inBiotechnology
Understanding Nurses’ Views on Dual-Diagnosis Care in Ghana
In a groundbreaking qualitative study, researchers Nsatimba, F., Sehularo, L., and Moagi, M. examine the intricate perceptions of nurses concerning…
Posted inBiotechnology
Essential Skills for Crisis Communication in Serious Illness
In a groundbreaking study, Rodriguez, Osman, and Lawton delve into the critical realm of crisis communication, particularly within the context…
Posted inBiotechnology
Gender Differences in Sjögren’s Disease: Impact on Survival
Recent research has opened new avenues in understanding the enigmatic condition known as primary Sjögren’s disease. This autoimmune disorder is…
Posted inBiotechnology
Global Strategies for Sarcopenia: Research and Practice Insights
Sarcopenia, a condition characterized by the gradual loss of muscle mass and function, poses a significant threat to the health…
Posted inBiotechnology
Novo Nordisk Foundation invests $860M in Danish institute nurturing homegrown biotechs
The Novo Nordisk Foundation is investing 5.5 billion Danish kroner ($860 million) in the BioInnovation Institute (BII) to help scale…
Posted inBiotechnology
Exploring PDR Gene Family and miRNAs in Wheat
In a groundbreaking study that promises to shed light on the intricate genetic adaptations of wheat, researchers have conducted a…
Posted inGenetics
Virtual Scientists Poised to Accelerate Discovery
Nick Edwards, PhD, CEO of Potato, has a “burning desire” to speed up scientific discovery. In an interview with GEN,…
Posted inGenetics
Automation: The Future of Labs is Autonomous, Not Just Automated
Jason Kelly, PhD Co-founder, CEOGinkgo Bioworks Most people still picture science as a person in a white coat, pipette in…
Posted inGenetics
The Throughput Paradox: Why Next-Generation Sequencing Bottlenecks Persist Beyond the Sequencer
Joe Mellor, PhD CSO, Co-founderseqWell The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We…
Posted inGenetics
An Agile, Intelligent and Sustainable Future: Biopharma Trends to Watch
Beate Mueller-TiemannChief Technology OfficerCytiva 2026 will be a pivotal year for biopharma. From digital transformation to an AI revolution to…